These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36259869)

  • 1. Treatment of longstanding alopecia areata universalis of the eyebrows/facial hair with oral and topical tofacitinib.
    Gonzalez Matheus GA; Herat A
    Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259869
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
    Cheng MW; Kehl A; Worswick S; Goh C
    J Drugs Dermatol; 2018 Jul; 17(7):800-803. PubMed ID: 30005104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
    Brown L; Skopit S
    J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alopecia areata with good response to tofacitinib].
    Maksimow A; Stintzing D; Wohlrab J
    Hautarzt; 2021 Jun; 72(6):525-527. PubMed ID: 33044559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent response to tofacitinib treatment in a patient with alopecia universalis.
    Erduran F; Adışen E; Aksakal AB
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Jun; 26(2):47-49. PubMed ID: 28632888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
    Liu LY; Craiglow BG; Dai F; King BA
    J Am Acad Dermatol; 2017 Jan; 76(1):22-28. PubMed ID: 27816293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
    Mrowietz U; Gerdes S; Gläser R; Schröder O
    Acta Derm Venereol; 2017 Feb; 97(2):283-284. PubMed ID: 27349217
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of systemic minoxidil and tofacitinib combination in treatment-resistant alopecia universalis.
    Dincer D; Tanacan E; Kose Ozkan C
    J Cosmet Dermatol; 2021 Jun; 20(6):1807-1809. PubMed ID: 33098729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tofacitinib for the treatment of alopecia areata affecting facial hair.
    Kerkemeyer KLS; Sinclair RD; Bhoyrul B
    Br J Dermatol; 2021 Sep; 185(3):677-679. PubMed ID: 33914907
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.
    Jabbari A; Nguyen N; Cerise JE; Ulerio G; de Jong A; Clynes R; Christiano AM; Mackay-Wiggan J
    Exp Dermatol; 2016 Aug; 25(8):642-3. PubMed ID: 27119625
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.
    Putterman E; Castelo-Soccio L
    J Am Acad Dermatol; 2018 Jun; 78(6):1207-1209.e1. PubMed ID: 29754888
    [No Abstract]   [Full Text] [Related]  

  • 13. Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature.
    Salman A; Sarac G; Ergun T
    Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tofacitinib in treatment of alopecia areata.
    Ferreira SB; Ferreira RB; Scheinberg MA
    Einstein (Sao Paulo); 2020; 18():eAI5452. PubMed ID: 32785452
    [No Abstract]   [Full Text] [Related]  

  • 15. Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients.
    Liu LY; Craiglow BG; King BA
    J Am Acad Dermatol; 2018 Feb; 78(2):403-404.e1. PubMed ID: 29108908
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: A systematic review and meta-analysis.
    Yu DA; Kim YE; Kwon O; Park H
    Indian J Dermatol Venereol Leprol; 2021; 87(5):621-627. PubMed ID: 34379968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata.
    Liu LY; King BA
    J Am Acad Dermatol; 2019 Jun; 80(6):1778-1779. PubMed ID: 30502414
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination tofacitinib and oral minoxidil treatment for severe alopecia areata.
    Wambier CG; Craiglow BG; King BA
    J Am Acad Dermatol; 2021 Sep; 85(3):743-745. PubMed ID: 31499158
    [No Abstract]   [Full Text] [Related]  

  • 19. Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
    Yu L; Yu H; Zhang S; Hao Y; Zhang S
    Front Immunol; 2022; 13():904156. PubMed ID: 35795663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic synergy between contact dermatitis from a wig-fixing device and tofacitinib on alopecia areata.
    Lee JS; Yoon HS; Cho S; Park HS
    J Dermatol; 2019 Apr; 46(4):e139-e140. PubMed ID: 30204259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.